Practices of Accompaniment of the Relatives of Patients in the AGonic

Clinical Trial Description

The objective of PROPAGE 2 is to establish a consensus on the practices for accompanying relatives during the agonic phase in the context of hospitalization in the palliative care unit by an interdisciplinary team. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT05721664` - Effect of Evidence-based Nursing Practices Training Program on the Competency of Nurses Caring for Mechanically Ventilated Patients	N/A
Completed	`NCT06366607` - Managing High-alert Medication Administration and Errors
Completed	`NCT04199065` - Impact of Good Practice Guidelines on Evidence-based Practice and Nurses' Work Environment	N/A
Completed	`NCT06370364` - Nurses' Practice of Safe Blood Transfusion in Surgical and Critical Care Units

See also

Status

Clinical Trial

Phase

Completed

NCT05721664 - Effect of Evidence-based Nursing Practices Training Program on the Competency of Nurses Caring for Mechanically Ventilated Patients

N/A

Completed

NCT06366607 - Managing High-alert Medication Administration and Errors

Completed

NCT04199065 - Impact of Good Practice Guidelines on Evidence-based Practice and Nurses' Work Environment

N/A

Completed

NCT06370364 - Nurses' Practice of Safe Blood Transfusion in Surgical and Critical Care Units

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04818684
Study type	Observational
Source	University Hospital, Bordeaux
Contact
Status	Completed
Phase
Start date	December 1, 2021
Completion date	May 15, 2022

Practices of Accompaniment of the Relatives of Patients in the AGonic Phase by an Interdisciplinary Team — PROPAGE2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms